BCTX, BCTXL, BCTXW, BCTXZ · CIK 0001610820 · operating
BriaCell Therapeutics Corp. (BCTXZ) is a pharmaceutical preparations company incorporated in British Columbia, Canada, listed on the Nasdaq. The stock currently trades at $0.17, down 1.55% today, with a 52-week range of $0.13–$0.15.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-62.19 | $-62.19 | -21344.8% | |
| 2024 | $-0.29 | $-0.29 | +77.7% | |
| 2023 | $-1.30 | $-1.30 | +24.9% | |
| 2022 | — | $-1.73 | — |